
HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
Author(s) -
Milana A. Bergamino,
Elena López-Knowles,
Gabriele Morani,
Holly Tovey,
Lucy Kilburn,
Eugene F. Schuster,
Anastasia Alataki,
Margaret Hills,
Hui Xiao,
Chris Holcombe,
Anthony Skene,
J. F. R. Robertson,
Ian Smith,
Judith M. Bliss,
Mitch Dowsett,
Maggie C.U. Cheang,
Abigail Evans,
Adrian Ball,
A. Johri,
Ali Nejim,
Alison Jones,
A. P. Corder,
Amanda Thorne,
Ambika Anand,
Amitabha Chakrabarti,
A. Robinson,
Anthony Skene,
Anupam Modi,
Ashraf Patel,
Ashutosh Kothari,
Brendan McFall,
Caroline Mortimer,
Caroline Lee,
Charlie Chan,
C. Abson,
Christopher Holcombe,
Christopher Hinton,
Ciaran Hollywood,
Claire Murphy,
Clare Crowley,
Claudia Harding-Mackean,
Clive Griffith,
Conrad Lewanski,
Daniel Rea,
David Hwang,
Derek A. Crawford,
Dinesh Thekkinkattil,
Douglas Ferguson,
Douglas Adamson,
Duncan Wheatley,
D. Ravichandran,
E.D. Babu,
Elaine Hyett,
Fawzia Ashkanani,
Fiona Hoar,
Frances Kenny,
Gary Dyke,
Geoffrey Sparrow,
Frédéric Gilbert,
Giles Cunnick,
Hafiz Algurafi,
Helen Sweetland,
Highes-Davies Prof,
Hisham Hamed,
Ian Smith,
Ian Laidlaw,
Ilyas Khattak,
Jacqueline C. Newby,
Jacqueline Rees-Lee,
Jalal Kokan,
J. Carl Barrett,
Jay Naik,
Jayant S Vaidya,
Jennifer Forrest,
Jitendra Parmar,
Jocelyn Adams,
John Fox,
Jonathan Roberts,
Jonathan I. Dawson,
Julie Doughty,
Jull Donnelly,
Kathleen Dunn,
Kian Chin,
Kieran Horgan,
Kamlesh Thakur,
Ludger Barthelmes,
Lynda Wyld,
Madhumita Bhattacharyya,
Maher Hadaki,
Makam Kishore,
Marcus Ornstein,
Maria Bramley,
Maria Bews-Hair,
Marina Parton,
Mark Sibbering,
Mark Kissin,
Mark Churn,
Martin Hogg,
Mary Quigley,
Matthew Hatton,
Matthew Winter,
Matthew Adelekan,
Michael Shere,
Michael J. Carr,
Michael A. Williams,
Mohammed Absar,
M. Sharif,
Muireann Kelleher,
Nawaz Walji,
Nicholas H. Williams,
Nicholas Gallegos,
Nigel Bundred,
Olivia Hatcher,
Perric Crellin,
Peter W. Crane,
P. K. Donnelly,
Peter Kneeshaw,
P.L. Walker,
Prakash Sinha,
Pud Bhaskar,
Racheal Soulsby,
Radha Todd,
Raghavan Vidya,
Rakesh Mehra,
R Prasad,
Ramsay Cutress,
Vishal Sharma,
Rebecca Roylance,
Rebecca Goranova,
Reem Salman,
Riccardo Bonom,
Richard S. Johnson,
Richard Sutton,
Rick Linforth,
Rob Coleman,
Robert Grieve,
Robert Leonard,
Robert Reichert,
Robert S. Kennedy,
Roshan Agarwal,
R. Allerton,
Russell Burcombe,
Ruth Davis,
Sankaran Narayanan,
S Chandrasekharan,
Sarah Vesty,
Seema Seetharam,
Serena Ledwidge,
Sajid Iqbal,
Shamaela Wahee,
Shobha Silva,
Simon Pain,
Simon Holt,
Simon Thomson,
Simon Smith,
S. Ellenbogen,
Simon Holt,
Siobhan Laws,
Stephen Y. Chan,
Stephen Johnston,
S. Holt,
Steven Thrush,
Stuart McIntosh,
Sumohan Chatterjee,
Susan Cleator,
Tamoor Usman,
Tayo Johnson,
Tibor Kovács,
Tracey Irvine,
Urmila Barthkur,
Vanessa Pope,
Victoria Alexandra Brown,
Vummiti Muralikrishna,
Walid Samra,
William Maxwell,
Zoë Winters
Publication year - 2022
Publication title -
ebiomedicine
Language(s) - English
Resource type - Journals
ISSN - 2352-3964
DOI - 10.1016/j.ebiom.2022.104205
Subject(s) - breast cancer , medicine , oncology , aromatase inhibitor , trastuzumab , biomarker , cancer research , cancer , aromatase , biology , genetics